News & Events

Regarded as a flagship event in the global lung health sector, WCLH 2025 marks the 56th edition of the World Conference on Lung Health. Hosted by the International Union Against Tuberculosis and Lung Disease (UNION), the conference was grandly held in Copenhagen, Denmark from November 18th to 21st. It attracted over 3,000 delegates from more than 130 countries and regions worldwide, bringing together top-tier public health institutions, international organizations, research institutions, and frontline medical teams to collaborate on strategies for lung health prevention and control. Under the core goal of "ending tuberculosis and advancing global lung health," the development of diagnostic technologies and service accessibility emerged as key topics of discussion across various forums.

Throughout the conference, academic exchanges and booth interactions formed a positive synergy, maintaining consistent momentum. Based on on-site feedback, we collaborated with partners to conduct targeted discussions addressing pain points across different scenarios: For resource-constrained regions, we jointly explored how to leverage microfluidic chip technology to simplify near-POC testing workflows and reduce reliance on professional laboratories. For home self-testing and primary screening, we worked together to optimize the preservation and testing protocols for tongue swab samples, ensuring accurate results even under non-professional operation. These practical dialogues grounded in on-site realities have clarified the direction of technological innovation and consolidated global consensus on collaborative advancement of lung health initiatives.

At a roundtable forum focusing on "Translating Innovative Diagnostic Technologies into Practice," a European research team pointed out that the standardized collection of tongue swab samples is a core challenge to its widespread adoption. The "ambient temperature preservation + one-step sample loading" solution proposed by GenDx, drawing on our own R&D experience, was recognized by on-site experts. Such cross-regional and interdisciplinary academic exchanges have deepened our understanding that the translation of molecular diagnostic technologies from the laboratory to the clinical frontline is never a breakthrough of a single technology, but an organic integration of technological innovation, scenario adaptation, and global collaboration. GenDx is further convinced that the combination of the "speed" of near-POC molecular diagnostics and the "ease" of tongue swab samples will become a crucial force in breaking down geographical and resource barriers.

Although this grand event integrating academia and practice has come to an end, the cooperation and exploration initiated thereby have just begun. We will translate all the sparks of ideas from academic exchanges and the real needs from booth interactions at the exhibition into clear directions for technological R&D and core basis for product optimization, continuing to deepen our expertise in the fields of near-POC molecular diagnostics and innovative sample applications. This reinforces our belief that with exhibitions as bridges and genetic technology as bonds, we will surely join hands with global partners to forge a solid defense for global lung health.